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Abstract
A unique Trp residue in the recombinant dIII component of transhydrogenase from human heart mitochondria (hsdIII),
and an equivalent Trp engineered into the dIII component of Rhodospirillum rubrum transhydrogenase (rrdIII.D155W), are
more fluorescent when NADP is bound to the proteins, than when NADPH is bound. We have used this to determine the
occupancy of the binding site during transhydrogenation reactions catalysed by mixtures of recombinant dI from the
R. rubrum enzyme and either hsdIII or rrdIII.D155W. The standard redox potential of NADP/NADPH bound to the dIII
proteins is some 60^70 mV higher than that in free solution. This results in favoured reduction of NADP by NADH at the
catalytic site, and supports the view that changes in affinity at the nucleotide-binding site of dIII are central to the mechanism
by which transhydrogenase is coupled to proton translocation across the membrane. ß 1999 Elsevier Science B.V. All
rights reserved.
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1. Introduction
Transhydrogenase is a proton pump, found in the
inner mitochondrial membranes of animal cells, and
in the cytoplasmic membranes of bacteria. It uses the
energy of the proton electrochemical gradient (vp) to
drive the reduction of NADP by NADH, and it
probably functions (a) in the supply of NADPH
for biosynthesis, and for glutathione reduction [1],
and (b) in the regulation of £ux through the tricar-
boxylic acid cycle [2]. The mechanism by which
transhydrogenase couples the translocation of
protons across the membrane to the transfer of re-
ducing (hydride) equivalents between NAD(H) and
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Abbreviations: rrdI, the NAD(H)-binding component of Rho-
dospirillum rubrum transhydrogenase; hsdIII the NADP(H)-bind-
ing component of human transhydrogenase; rrdIII.E155W, the
NADP(H)-binding component of R. rubrum transhydrogenase
with a Trp residue substituted for Glu155; AcPdAD, acetyl
pyridine adenine dinucleotide (oxidized form)
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NADP(H) is only poorly understood (for reviews,
see [3^5]).
NADHNADP  xHOUTINAD NADPH xHIN
1
Earlier determinations of the value of x were unreli-
able (reviewed, in detail, [6]). A recent investigation
yielded x = 1 [7].
The enzyme has a tripartite structure. The dII
component spans the membrane, probably via 10^
14 hydrophobic helices [8^11]. The dI and dIII com-
ponents protrude from the membrane (on the matrix
side in mitochondria and on the cytoplasmic side in
bacteria), and possess the binding sites for NAD/
NADH and NADP/NADPH, respectively. The
amino acid sequence of dI is similar [12] to that of
the soluble protein, alanine dehydrogenase, whose
crystal structure has recently been solved [13]. We
suggested [14,15] that, like alanine dehydrogenase,
dI comprises two domains, each of which has the
open, twisted LKL structure of the Rossmann fold;
one of these (domain I.2) binds the NAD/NADH
(see also [16]), the other (domain I.1) has an un-
known function. An emerging NMR structure shows
that the dIII protein also adopts the Rossmann fold
[17,18]. We [19] and others [20] have stressed that
coupling between proton translocation and transhy-
drogenation is probably achieved through vp-in-
duced changes in nucleotide-binding a⁄nity. Our
view is that dI.NADH serves as a passive hydride
donor in the reaction, and that the crucial changes
in binding energy occur at the dIII nucleotide-bind-
ing site [3,19]. Thus, the mechanism of H pumping
by transhydrogenase might have more in common
with the cation-transporting ATPases than with the
redox proteins of the respiratory and photosynthetic
electron transport chains.
During the last 5 years, the dI and dIII compo-
nents of transhydrogenases from several species have
been isolated using recombinant DNA technology,
and puri¢ed [21^27]. Even in the absence of the
membrane-spanning dII component, simple mixtures
of dI and dIII yield complexes which catalyse trans-
hydrogenation [23^28]. The hydride transfer step in
the dI:dIII complexes, and nucleotide exchange at
the dI-binding site, are rapid, but the net rates of
forward and reverse transhydrogenation (see Eq. 1)
are very slow due to limiting rates of release of
NADPH and NADP, respectively, from dIII in
the absence of dII, as ¢rst shown [24].
In stopped-£ow experiments, the hydride transfer
step from NADPH to the NAD analogue, acetyl-
pyridine adenine dinucleotide (AcPdAD), in dI:dIII
complexes, is revealed as a burst prior to establish-
ment of the slow steady-state rate [27,29,30]. There
are no redox intermediates in this reaction; hydride
transfer proceeds directly and rapidly from one nu-
cleotide to the other, indicating that the nicotinamide
rings of the two nucleotides must be brought into
apposition during catalysis. A comparison of the
characteristics of the ‘forward’ (AcPdADHC
NADP), and ‘reverse’ (NADPHCAcPdAD), re-
actions suggested that the equilibrium constant of
the hydride transfer step on the Rhodospirillum ru-
brum dI:dIII complex is altered by about 6^16-fold,
relative to that in free solution, in favour of NADPH
and AcPdAD [31]. This has important conse-
quences for the mechanism of transhydrogenation
with physiological nucleotides in the forward direc-
tion.
In this report, we describe a di¡erent approach
towards understanding the redox chemistry at the
catalytic site. We make use of a recent observation
by Fjellstrom et al. [26,28], that £uorescence emission
from the single Trp residue of dIII of Escherichia coli
transhydrogenase is lower when NADPH is bound to
the protein than when NADP is bound. We ¢nd
that the equivalent Trp in dIII from human heart
(hsdIII), and a Trp engineered into R. rubrum dIII
(rrdIII), behave similarly. We also make use of the
fact that, in simple mixtures of either rrdI+rrdIII or
rrdI+hsdIII, nucleotide exchange with dI, and hy-
dride transfer, take place very rapidly, whereas nu-
cleotide release from dIII is extremely slow
[27,29,30]. Under these conditions, AcPdAD/AcPd-
ADH in solution reach equilibrium with bound
NADP/NADPH and, thus, we are able to estimate
the standard redox potential of nucleotide in the
dIII-binding site.
2. Materials and methods
The dI protein of R. rubrum transhydrogenase
(rrdI), and the dIII protein of the Homo sapiens en-
zyme (hsdIII) ^ the ‘long form’ (see [27]), were sep-
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arately expressed in E. coli, strain C600 and strain
BL21(DE3), respectively, from the constructs pCD1
[21] and pSJP2 [27], respectively, and puri¢ed by col-
umn chromatography.
Mutagenesis of rrdIII was carried out using the
Stratagene Quikchange kit, and mutagenic primers
supplied by Alta Bioscience. After mutagenesis, the
nucleotide sequences of coding regions were checked
for polymerase errors using an Applied Biosystems
373A automatic sequencer according to the manufac-
turer’s instructions. A BamHI site was engineered
into the 5P end of the DNA coding for rrdIII in
the construct pCD2 [24], and the internal NdeI site
was removed using the mutagenesis kit. Thus,
C2757ATATG in the nucleotide sequence [32,33] was
changed to C2757ACATG, which does not alter the
amino acid sequence of the translation product. The
NdeI and BamHI fragment limiting the dIII coding
region was excised from an agarose gel, and inserted
into the multiple cloning site of pET11c (Novagen)
to give pNIC2. This construct was transformed into
BL21(DE3), and used for the expression of wild-type
rrdIII. The DNA coding for mutant protein
rrdIII.E155W (dIII of R. rubrum transhydrogenase,
but with Glu155 changed to a Trp residue) was iso-
lated using pNIC2 as the template, designated
pJDV1, and transformed into BL21(DE3) for expres-
sion. Wild-type rrdIII and rrdIII.E155W were puri-
¢ed, as described [24]; during column chromatogra-
phy, the behaviours of the mutant and wild-type
proteins were indistinguishable.
Note that in this report, we number amino acid
residues according to the sequence of the isolated
dIII proteins. Thus, Met1 of rrdIII is equivalent to
Met262 of PntB (the L subunit of the complete R.
rubrum enzyme), and Met1 of hsdIII is equivalent to
Met837 of the mature protein of human transhydro-
genase (a single polypeptide).
All protein preparations were checked for purity
(s 95%) by SDS-PAGE, and concentrations were
determined using the microtannin assay [34]. The
amounts of bound nucleotides in the dIII proteins
were measured after acid or alkaline extraction, as
appropriate, and as described [24,35]. Where re-
quired, NADP(H) on dIII was converted either to
the fully oxidized or fully reduced form, as described
[18,29].
Steady-state rates of transhydrogenation were
measured as the reduction of AcPdAD by
NADPH, or by NADH in the presence of NADP,
at 375 nm on a Perkin Elmer V16 spectrophotometer,
using an extinction coe⁄cient of 6.1 mM31 cm31
[31,36].
Measurements of tryptophan £uorescence were
carried out at 25‡C in a magnetically stirred, 1U1
cm cuvette, using a Spex FluoroMax with slitwidths
set to 4.25 nm, as previously described [21]. The in-
ner ¢ltering e¡ect of the nucleotides was compen-
sated using the algorithm given [37], or by addition
of a non-binding nucleotide (see below). Nucleotide
concentrations of stock solutions were determined
from their UV absorbance.
3. Results
3.1. Trp £uorescence from hsdIII
The isolated recombinant forms of the dIII com-
ponents from the transhydrogenases of R. rubrum
[24], E. coli [26], H. sapiens [27], and probably that
from Bos taurus [25], are associated with 1 mole of
tightly bound nucleotide (NADP/NADPH) per mol
of protein. Nucleotide extraction experiments indi-
cated that approx. 95% of the nucleotide on the
preparations of H. sapiens dIII protein (hsdIII)
used in this report is NADP, and approx. 5% is
NADPH (results not shown). The £uorescence emis-
sion from the single Trp residue of the dIII protein
of E. coli transhydrogenase was lowered when bound
NADP was replaced by NADPH [26,28]. The
hsdIII protein has an equivalent Trp residue,
Trp154 (position 990 in the complete transhydroge-
nase sequence [38], and see [27]). Fig. 1A shows that,
as in the experiments with E. coli dIII, the £uores-
cence emission of Trp154 was lowered (by approx.
24% without any shift in the wavelength of the emis-
sion band), when bound NADP was replaced by
the reduced nucleotide.
The kinetics of the Trp £uorescence change that
follow from the addition of NADPH to hsdIII pre-
loaded with NADP, are shown in Fig. 2A. The
initial, rapid £uorescence decrease is the result of
‘inner ¢ltering’ by the added nucleotide (at both
the excitation and emission wavelengths). Following
this e¡ect, the Trp £uorescence was quenched with
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approximately ¢rst order kinetics, as the added
NADPH from solution exchanged with NADP on
hsdIII. The apparent ¢rst order rate constant of the
£uorescence quenching increased with the initial
NADPH concentration, approaching a maximum at
approx. 0.2 s31 (not shown). The limiting value at
high NADPH concentrations (s 20 WM), when nu-
cleotide re-binding becomes relatively fast, should
correspond to the koff for NADP release from the
protein (see also [26,28]). Within error, the value is
similar to that calculated from experiments in which
NADP released from dIII was reduced with isoci-
trate dehydrogenase (0.014 s31 [24]). The addition of
NADH to hsdIII under similar conditions to those in
Fig. 2A (notably, in the absence of dI) caused only
the inner ¢ltering e¡ect (experiment not shown); it
did not cause quenching of the Trp £uorescence ^
NADH does not bind to dIII protein (but see below,
and Fig. 2C).
For the experiment shown in Fig. 2B, the hsdIII
had been pre-loaded with NADPH (see [29]), and
washed to remove excess nucleotide. The addition
of NADP then led initially to an inner ¢ltering
e¡ect on the Trp154 £uorescence, followed by a £u-
orescence increase, presumably as the added nucleo-
tide displaced the bound NADPH. At high concen-
trations of NADP, the apparent ¢rst order rate
constant for the £uorescence increase approached a
limiting value of 0.003 s31, which is consistent with
the koff value for NADPH dissociation from hsdIII
calculated from experiments in which released nu-
cleotide was oxidized by glutathione reductase
(koffW0.008 s31) [24]. As expected from its inability
to bind, the addition of NAD to hsdIII under sim-
ilar conditions to those in Fig. 2B caused only the
inner ¢ltering e¡ect (not shown).
A simple mixture of hsdIII and the recombinant dI
protein from R. rubrum transhydrogenase (rrdI) cat-
alyses transhydrogenation [27]. The hydride transfer
step in the dI:dIII complex, and nucleotide binding
to, and release from, dI are very rapid, but the
steady-state rates of the ‘forward’ and ‘reverse’ reac-
tions (see Eq. 1) are strongly limited by very slow
release from dIII of products, NADPH and NADP,
respectively. Observations on the £uorescence of
Trp154 in dIII now present us with the opportunity
Fig. 1. The £uorescence spectra of hsdIII (A), and rrdIII.E155W (B), in their NADP-bound and NADPH-bound forms. Experiments
were performed using 1.0 WM hsdIII (A) or 1.0 WM rrdIII.E155W (B) in 20 mM MOPS, pH 7.2. Excitation was at 280 nm. Upper
curves in each panel: the £uorescence emission spectra were recorded with the proteins in their NADP forms (see Section 2). Lower
curves in each panel: the £uorescence emission spectra with the proteins mainly in their NADPH forms (obtained by adding 20 WM
NADPH, see Figs. 2 and 3). In each spectrum, the shoulder at about 310 nm is due to the water Raman band.
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Fig. 2. Changes in the £uorescence of Trp154 in hsdIII resulting from changes in nucleotide occupancy. Experimental conditions as in
Fig. 1. Fluorescence emission was measured at 338 nm. The dotted lines show the extent of the inner ¢ltering e¡ect of the added nu-
cleotide, calculated as described [37]. Experiments A, C and D were carried out with the protein initially in its NADP form (see Sec-
tion 2). Experiment B was carried out with the protein in its NADPH form [30,31]. The concentrations shown in the ¢gure represent
¢nal values. The vertical scale is the same for all parts of the ¢gure, but note di¡erences in the time scales (see horizontal bars).
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to examine changes in the occupation of the nucleo-
tide binding site on this protein that are consequent
upon hydride transfer either to or from nucleotide
bound to dI.
(1) Fig. 2C shows that the Trp £uorescence from
hsdIII.NADP was quenched following the addition
of rrdI plus NADH. In experiments in which the
order of addition of dI protein and NADH was re-
versed (not shown), it was established that both com-
ponents were necessary for the response. Note that
the £uorescence emission from Trp72 in dI [21] was
negligible under the conditions shown because the
concentration of this protein was relatively low.
The decrease in Trp £uorescence, shown in Fig.
2C, clearly results from the reduction of the NADP
on dIII by NADH on dI, and the fact that the prod-
uct NADPH is slow to dissociate from the dIII pro-
tein. Very low rrdI concentrations were required to
produce this response; in Fig. 2C the dI concentra-
tion was one ¢ftieth that of dIII. This is because the
exchange of nucleotides on dI, the dissociation of the
complex, and the re-association of dI and dIII, are
all fast relative to the rate of nucleotide release from
dIII; e¡ectively, dI can visit many dIII molecules
during the time taken for dIII to release its NADPH
[24]. As expected, the rate of the £uorescence
quenching increased markedly when the dI concen-
tration was raised (results not shown).
(2) The experiment shown in Fig. 2D complements
that shown in Fig. 2C. To begin, a low concentration
of NADPH was added to hsdIII partially to displace
the bound NADP ; it resulted in the expected
quenching of the Trp154 £uorescence (compare Fig.
2A). The subsequent addition of NAD and dI led
to a £uorescence increase, as the NADPH on dIII
was oxidized by hydride transfer. Again, for the rea-
sons given above, only low concentrations of dI were
required to elicit this response. Qualitatively similar
results were obtained using a combination of the
hsdIII and dI proteins plus the NAD analogue,
AcPdAD, and this forms the basis for the determi-
nation of the standard redox potential of NADP(H)
in its binding site (see below).
3.2. Trp £uorescence from rrdIII.E155W
The dIII component of R. rubrum transhydroge-
nase is devoid of Trp residues; its near-ultraviolet
£uorescence spectrum is dominated by Tyr emissions
[24]. The equivalent of Trp154 in hsdIII in the R.
rubrum protein is a Glu residue (Glu155). In
rrdIII.E155W we have replaced the Glu residue
with a Trp (see Section 2). Steady-state rates of ‘re-
verse’ and ‘cyclic’ transhydrogenation catalysed by
this mutant protein in mixtures with wild-type rrdI,
and its ¢rst order rate constants for nucleotide re-
lease, were similar to those of wild-type dIII within a
factor of two (Table 1). See [24,39] for a detailed
Table 1
Catalytic properties of rrdIII.E155W
rrdIII.E155W Wild-type dIII
Apparent ¢rst order rate constant for NADP release (s31)a 0.063 0.030
Cyclic transhydrogenationb
Vmax (s31) 1540 1610
Concentration of dIII required to give half-maximal rate (nM) 32 26
Reverse transhydrogenationc
Vmax (s31) 1.31 1.24
Concentration of dI required to give half-maximal rate (nM) 210 170
aNADP released from the dIII protein (2.0 WM) was trapped with glucose-6-phosphate dehydrogenase (3.3 units ml31) and glucose
6-phosphate (2.0 mM) in 50 mM KCl, 20 mM MOPS, pH 7.2, and the £uorescence was recorded, as described [24]. The value for the
wild-type protein was taken from [24].
bCyclic transhydrogenation is the reduction of AcPdAD by NADH in the presence of NADP(H) [19,24]. The reaction was measured
in 20 mM MOPS, pH 7.2 with 6.5 nM rrdI, 200 WM AcPdAD, 100 WM NADH and 20 WM NADP. Vmax was estimated from dou-
ble reciprocal plot as the concentration of dIII tended to in¢nity.
cReverse transhydrogenation was measured as the reduction of AcPdAD (100 WM) by NADPH (200 WM) in 20 mM MOPS, pH 7.2.
The rrdIII concentration (either rrdIII.E155W or wild-type) was 845 nM. Vmax was estimated from double reciprocal plot as the con-
centration of dI tended to in¢nity.
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Fig. 3. Changes in Trp £uorescence of rrdIII.E155W resulting from changes in nucleotide occupancy. Conditions as in Fig. 1. The
dotted lines show the extent of the inner ¢ltering e¡ect of the added nucleotide, calculated as described [37]. Experiments A, C and D
were carried out with the protein initially in its NADP form (see Section 2). Experiment B was carried out with the protein in its
NADPH form [30,31]. The concentrations shown in the ¢gure represent ¢nal values. The vertical scale is the same for experiments A,
C, and D. In experiment B, the vertical scale is ampli¢ed by 4, and a section, equivalent to 75% of the £uorescence change upon ad-
dition of the NADP, has been removed. Note di¡erences in the time scales (see horizontal bars).
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discussion of these processes. These results indicate
that the amino acid substitution does not have sig-
ni¢cant e¡ects on the catalytic properties of the pro-
tein.
The £uorescence emission spectrum of
rrdIII.E155W (Fig. 1B) closely resembles that of
hsdIII and, as with the latter, was less intense
(W30%) when NADPH was bound to the protein,
than when NADP was bound. Fig. 3 shows a set of
experiments with rrdIII.E155W that is similar to the
set shown in Fig. 2 with hsdIII; the results are closely
comparable. Fluorescence changes accompanying the
displacement of NADP from rrdIII.E155W.
NADP by NADPH (Fig. 3A), and the displacement
of NADPH from rrdIII.E155W.NADPH by NADP
(Fig. 3B), were slower than in the equivalent human
protein (Fig. 2A and B, respectively), but this mirrors
the slower rates of nucleotide release from rrdIII
[24] than from hsdIII [27], as measured by other
procedures. In particular, the £uorescence increase
upon addition of NADP to NADPH-loaded
rrdIII.E155W (Fig. 3B) was extremely slow, and
was incomplete with nucleotide concentrations up
to about 50 WM (compare koffW6U1034 s31 [24]);
above this concentration, the inner ¢ltering e¡ect of
the added nucleotide became too large for proper
measurement. The value of koff for NADP, calcu-
lated from the Trp £uorescence decrease upon addi-
tion of NADPH to NADP-loaded rrdIII.E155W
(Fig. 3A), was 0.063 s31, comparing favourably
with the value of 0.058 s31 estimated by trapping
released NADP with glucose-6-phosphate dehydro-
genase (Table 1). Fig. 3C and D show the e¡ects on
the Trp155 £uorescence of oxidizing/reducing
NADP(H) bound to rrdIII.E155W by hydride trans-
fer to, or from, NAD(H) on rrdI protein. The results
are qualitatively similar to those shown in Fig. 2C,D
for the hybrid system.
3.3. The redox potential of bound NADP(H)
The ability to determine the occupancy of hsdIII
and rrdIII.E155W by NADP/NADPH from the
Trp £uorescence also allows us to estimate the stand-
ard redox potentials of these nucleotides in their
binding sites. Each data point in Fig. 4 was deter-
mined as follows. To a mixture of rrdI and either
hsdIII or rrdIII.E155W (in the NADP-bound
forms) was added a mixture of AcPdAD and AcPd-
ADH. Because (a) the binding and release of
AcPdAD and AcPdADH to and from dI and (b)
the hydride transfer reaction are both very rapid rel-
ative to the release of NADP and NADPH from
the dIII protein, it is assumed that the reaction,
AcPdADsol  dIII:NADP I
dI protein
AcPdADHsol  dIII:NADPH 2
quickly reaches equilibrium (AcPdADsol and
AcPdADHsol represent the solution forms of the nu-
cleotide). The Eh of NADP/NADPH in the cata-
lytic site is then equal to that of the AcPdAD/
AcPdADH in solution, and the latter can be calcu-
lated from the added quantities, after making a small
correction for the change in concentrations on the
approach to equilibrium. The metastable level of
the £uorescence of either Trp154 (for hsdIII) or
Trp155 (for rrdIII.E155W) within a few seconds of
mixing was used to determine the fractional occupa-
Fig. 4. The standard redox potential of NADP/NADPH on
hsdIII and on rrdIII.E155W4. The experimental conditions were
similar to those in Figs. 2 and 3, but using either 100 nM rrdI
and 1.0 WM hsdIII (a), or 100 nM rrdI and 1.0 WM
rrdIII.E155W (b). Mixtures of AcPdAD and AcPdADH (total
20 WM) were added to set the redox state of the NADP/
NADPH on dIII (see text). The £uorescence was scaled on the
basis that the emission prior to the addition of nucleotides was
equivalent to an occupancy of 95% NADP, 5% NADPH, and
that the emission reached after equilibration with 40 WM
NADPH corresponds to an occupancy of 100% of the reduced
nucleotide. The solution Eh of the AcPdAD/AcPdADH was
calculated using a value for Em7:2 =30.254 V [42].
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tion by NADP and NADPH of the dIII protein.
The relationships between the solution Eh of the
AcPdAD/AcPdADH and the ratio of dIII-bound
NADP/NADPH, shown in Fig. 4, both ¢t Nernst
curves (n = 2) with an E7:2 value for hsdIII of 30.266
V, and for rrdIII.E155W of 30.253 V.
In principle, these titrations can be performed with
NAD/NADH instead of AcPdAD/AcPdADH. In-
deed, trial experiments gave results that were in qual-
itative agreement with the data of Fig. 4. However,
because the Em7:2 of NAD/NADH is approx. 60^70
mV more negative than that of AcPdAD/AcPd-
ADH (and of the bound NADP/NADPH), a quan-
titative analysis with the physiological nucleotides
was technically more di⁄cult. Thus, even very low
ratios of NADH/NAD were su⁄cient extensively to
reduce the dIII.NADP, and consequently the error
on the measured ratio was considerably greater.
4. Discussion
Our results support the conclusion that a non-es-
sential Trp residue in the dIII protein of transhydro-
genase (Trp154 in hsdIII and Trp155 in
rrdIII.E155W, this work, and LTrp415 in E. coli
dIII [26,28]) is more £uorescent when NADP is
bound to the protein than when NADPH is bound.
Furthermore, we show that the £uorescence change
of the Trp can be used to monitor the occupancy of
the nucleotide-binding site in dIII during hydride
transfer to and from NAD(H) bound to dI protein.
The Trp residue is located in, what we have provi-
sionally called, loop D, of the dIII NMR structure
[18], and is close enough to the bound nucleotide (in
the region of 17 Aî from the nicotinamide ring, M.
Jeeves, personal communication) to transfer reso-
nance energy by a Fo«rster mechanism.
Recently, we showed that, during the pre-steady-
state burst of transhydrogenation from AcPdADH
to NADP by dI:dIII complexes, the reaction pro-
ceeded beyond the position expected for the hydride
transfer equilibrium in free solution [31]. This was
evidently the result of a bias to the equilibrium con-
stant on the enzyme in the ‘forward’ direction. We
estimated the on-enzyme equilibrium constant from
the extent of the burst at di¡erent nucleotide concen-
trations, and we attempted to ¢t kapp values for the
burst of ‘forward’ and ‘reverse’ transhydrogenation
to kf and kr for the hydride transfer step. In the
present experiments a di¡erent approach is em-
ployed. We have determined the fractional occu-
pancy of the NADP(H)-binding site by monitoring
Trp £uorescence under conditions in which exchange
of AcPdAD and AcPdADH on dI with that in so-
lution, hydride transfer and dissociation/re-associa-
tion of dI:dIII are all very fast relative to release
of NADP and NADPH from dIII. Under these
conditions the reaction described by Eq. 2 will rap-
idly reach equilibrium, i.e. the redox potential of the
bound NADP/NADPH will take on the same value
as that of the AcPdAD/AcPdADH in solution. Be-
cause the dI concentration is kept low, the concen-
tration of bound AcPdAD and AcPdADH will be
negligible at all but extreme ratios of oxidized to
reduced nucleotide, and can be ignored. Thus, be-
cause the standard redox potential of AcPdAD/
AcPdADH in solution is fortuitously similar to
that of the bound NADP/NADPH, the most reli-
able Eh values, where AcPdAD/AcPdADHW1, are
those close to the Em of the bound nucleotide on dIII
(Fig. 4). The fact that the data ¢t to a Nernst curve
support the view that the reaction is operating at
equilibrium.
The standard redox potential of the NADP(H) in
the binding site of dIII is shifted by +0.073 V (rrdIII)
or by +0.060 (hsdIII) and this must result from sta-
bilization on the protein of the reduced relative to
the oxidized nucleotide by a factor of approx. 270 in
rrdIII and approx. 100 in hsdIII. Now, isolated rrdI
binds NADH about ten times more tightly than
NAD (Kd values, determined by equilibrium dialy-
sis, are approx. 30 WM and approx. 300 WM, respec-
tively [40]). Thus, assuming that the nucleotide bind-
ing constants are not a¡ected by interactions
between dI and dIII, the equilibrium constant for
hydride transfer on dI:dIII complexes,
dI:NADH : dIIINADPIdI:NAD : dIIINADPH
3
is W27 for rrdI+rrdIII (which compares with a value
in the range of 6^16 in our earlier stopped-£ow de-
termination [31]), and W10 for rrdI+hsdIII. In view
of the errors, particularly in the estimation of Keq
from the pre-steady-state burst, the agreement is rea-
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sonable. The key ¢nding is that the equilibrium con-
stant is signi¢cantly greater than the value of approx.
1.0 in free solution.
These results can be considered in the context of
the ‘binding-change mechanism’ of proton pumping
by transhydrogenase [3,19,31], so described because
of its analogy with that proposed for the F1F0-ATP-
ase [43]. In this mechanism NADH binds to dI of the
intact enzyme and serves as a passive donor of hy-
dride equivalents; the binding a⁄nities for NADH
and NAD are thought not to change during the
catalytic cycle [40,41]. NADP binds with moderate
a⁄nity to the ‘open’ conformation of the dIII com-
ponent of the intact enzyme. Hydride transfer does
not take place in this state, but an interaction with
vp (e.g. through proton binding from the p-phase,
either to dII, or to dIII via dII) leads to an ‘occluded’
conformation in which NADP (and NADPH) are
prevented from dissociation, in which NADP is de-
stabilized relative to NADPH, and in which rapid
hydride transfer is permitted. Note that the process
of occlusion is necessary in this mechanism to permit
the vp-induced switch in the NADP(H)-binding af-
¢nity whilst preventing nucleotide expulsion from the
site. It might involve an increase in hydrogen bond
contact between the nicotinamide ring, or its ribose,
and the protein, or the movement of a protein seg-
ment over the nucleotide. The C4 position on the
pro-S face of the nicotinamide ring must, however,
remain accessible to nucleotide bound to the dI pro-
tein to allow H3 transfer. Following the redox reac-
tion between the bound nucleotides, a further input
of energy from vp (e.g. H release to the n-phase)
leads to regeneration of the ‘open’ state from which
NADPH can dissociate. Isolated dIII, and the dI:
dIII complex, are permanently locked into the
‘occluded’ state, where we see that, even though
NADH binds much more tightly than NAD
(which, in itself, would lower the equilibrium con-
stant), NADPH binds very much more tightly than
NADP. This means that, whilst the hydride transfer
step is not directly coupled to proton trans-
location, the di¡erences in the nucleotide binding
energies, and the rapid reaction rate, ensure that
the dI.NAD :dIII.NADPH state is more populated
than dI.NADH:dIII.NADP. Assuming that similar
arguments also apply in the intact enzyme, this de-
vice, since it immediately precedes the rate-limiting
step, would kinetically favour the reaction in the
‘forward’ direction.
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